Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids

No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients

(2014) Maria Romina Girotti et al.   Molecular Oncology

Tubulin: an example of targeted chemotherapy

(2013) Jenny Seligmann et al.   Future Medicinal Chemistry

Tumor adaptation and resistance to RAF inhibitors

(2013) Piro Lito et al.   NATURE MEDICINE

Challenging resistance mechanisms to therapies for metastatic melanoma

(2013) Lucio Tentori et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Adoptive Immunotherapy of Advanced Melanoma

(2012) Ronnie Shapira-Frommer et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012

(2012) Claus Garbe et al.   EUROPEAN JOURNAL OF CANCER

A Melanoma Molecular Disease Model

(2011) Smruti J. Vidwans et al.   PLoS One

Treatment for metastatic malignant melanoma: Old drugs and new strategies

(2009) Roger Mouawad et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Microtubule dynamics as a target in oncology

(2008) April L. Risinger et al.   CANCER TREATMENT REVIEWS

Melanoma epidemiology and trends

(2008) Claus Garbe et al.   CLINICS IN DERMATOLOGY